Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Major metabolites of benzo[a]pyrene by MFO system O OH O H H HO H OH H 9,10-DHDO 9,10-oxide O 1,6-Q 1-OH O 11 12 1 2 10 3 9 8 O 7 OH 6,12-Q H H 4 5 6 benzo[a]pyrene OH HO H O 3,6-Q H 4,5-DHDO 4,5-oxide 6-OH O HO O OH H 3-OH* H O H H OH 7,8-DHDO 7,8-oxide 7-OH, 9-OH, 12-OH and the 4,5-Q have also been reported O H H HO HH OH diolepoxide Arene oxide phenol rearrangement OH H O H OH H O H Stereochemistry of hydration by epoxide hydrolase H HO O H H OH H BP diolepoxide stereo isomers H HO HO H _ -7,8-dihydrodiol (+) H O H H H HO HO H O H H HO HO H _ -syn (+) _ -anti (+) (+)-anti: 7R,8S,9S,10R-BPDE R, S CONVENTION A D B C A>B>C S A>C>B R Lowest priority atom oriented towards rear, direction of rotation is determined on the front face. Priority is assigned by atomic number; when atoms are of equal atomic number, the atoms bonded to the atoms under consideration are considered. Adducts of anti-BPDE with exocyclic amino groups of nucleobases Heavy lines show the aromatic π-system conjugated with, and stabilizing the incipient positive charge resulting from attack at epoxide ring. This situation favors addition adjacent to aromatic ring. .N. H + 2 O - N d R N O H N d R N H N N N N H N H N H H O H H O H H O H H O H H O H H O H (+)-trans-anti--BPDE:N2-dGuo adduct at primer-template junction 5' Oxidized angular ring Distal end of pyrene system adduct of (-)-trans-anti-BPDE with N6-dAdo: opposite dThyd from N-Ras fragment 5 face of dAdo Looking down helix axis Looking perpendicular to helix axis cis adduct of (+)-anti-BPDE at N6 of dAdo 5 face of dAdo (-)-trans-anti-5-methylchrysene:dGuo adduct at the hindered bay region 5' 3' 1 2 3 4 5 CH3 (+)-trans-anti-benzo[g]chrysene:dAdo Inset: benzo[g]chrysene skeleton R,S-trans-anti-benzo[c]phenanthrene:dGuo S R benzo[ c]phenanthrene classical intercalation 5-insertion S-trans-anti-B[c]Ph 1(S) 5…C[G*]C… normal duplex classical intercalation 3-insertion R-trans-anti-B[c]Ph 1(R) 5…C[G*]C… normal duplex BAY REGION THEORY If a PAH has a bay region and shows genotoxic activity, the ultimate active metabolite will be the bay region diolepoxide. d O Nu transition state for opening of bay region epoxide heavy lines indicate the aromatic p-aromatic system Aflatoxin B1 activation O O O 2 O 1 O 3 O 9 5 O O 7 O O 4 OCH3 O 8 OCH3 endo (minor) human CYP3A4 6 O O aflatoxin B 1 AFB1 O OCH3 O O Carcinogenic potency determined by: O 1. Intrinsic activity of ultimate active metabolite 2. Proportion of metabolic pathway leading to ultimate active metabolite exo (major) AFB1-8,9-oxide Albumin lysine lysine lysine Reactions of AFB1-dGuo adduct O O O OCH3 HO H H HO O O hydrolysis O O O O N HN H2N HO H H N OCH3 O O N depurination AFB1-FAPy dGuo adduct N9 N7 Vinyl chloride activation ETHENO ( ADDUCTS FROM VINYL CHLORIDE O O N HN N N N N N N N2,3-dGuo N N 1,N2-dGuo N N N N N N N O 3,N4-dCyd 1,N6-dAdo N7-ADDUCT O O H2C CH N+ N N HN H2N N N7-(2-oxoethyl)-dGuo ACTIVATION OF DIMETHYLNITROSAMINE GENERAL STRUCTURE R N N H3C N N O H3C dimethylnitrosamine (DMN) O R' C-hydroxylation by MFO HOH2C N N O H3C non-enzymatic H N N O H3C monomethyl nitrosamine + N N OH H3C azotic acid CH2O H3C+ + N 2 + HO - Activation of 2-AAF (general for amines) other amines of commercial importance N H 2 2 - a m in o n a p h th a le n e - n a p h th y la m in e H 2 N N H 2 4 , 4 '- a m in o b ip h e n y l C l H 2 N C l C H 2 N H 2 4 , 4 '- d ia m in o - 3 , 3 '- d ic h lo r o d ip h e n y lm e t h a n e m e th y le n e b is ( o - c h lo r o a n ilin e ) M O C A Nitrenium ion adducts O NH NH 2 N N N dR NH O NH C8 adduct of AAF H 2N NH N N C1 adduct of AAF N dR O NH NH 2 N N N NH dR C8 adduct 1-aminopyrene Activation of nitroaromatics-multiple pathways, MFO and nitroreductase Other important environmental nitroPAH H N OCOCH3 Pathway A Pathway B R Pathway C Pathway D 1 OAT NO NO2 NH+ H N OH 2 3 reduce R R reduce R P450 nitrenium ion P450 reduce NH2 NO2 binding to DNA R R NO2 3-nitrofluoranthene R O NAT H N COCH3 NO2 NO2 2-nitrofluoranthene R R binding to DNA P450 - O + carbonium ion + N COCH3 HO N COCH3 R R binding to DNA R = -OH OAT =O-acetyltransferase NAT =N-acetyltransferase nitrenium ion CH3COO N COCH3 OAT R Deamination via diazotization reaction Deamination by bisulfite reaction Direct acting mutagens O H2N CH3 N NO H 2O N-methyl- N-nitrosourea (MNU) NH HN O2N CH3 N NO O CH3 HN NO + methylnitrosamine H2O N-methyl- N'-nitro-N-nitrosoguanidine (MNNG) H2N OH carbamic acid O CH3 HN NO + methylnitrosamine O2NN NH2 H nitrourea O H3C S OCH3 O H3C O methylmethanesulfonate O H3CO S OCH3 O dimethyl sulfate propylene oxide O O H2C CH2 -propiolactone CH2CH2Cl O O H2C P CH2 ethylene oxide N N CH CH Cl 2 2 O cyclophosphamide